Product Details for NDA 021014
TRILEPTAL (OXCARBAZEPINE)
150MG
Marketing Status: Prescription
300MG
Marketing Status: Prescription
600MG
Marketing Status: Prescription
150MG
Marketing Status: Prescription
Active Ingredient: OXCARBAZEPINE
Proprietary Name: TRILEPTAL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N021014
Product Number: 001
Approval Date: Jan 14, 2000
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status: Prescription
Patent and Exclusivity Information
TRILEPTAL (OXCARBAZEPINE)
Proprietary Name: TRILEPTAL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N021014
Product Number: 001
Approval Date: Jan 14, 2000
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status: Prescription
Patent and Exclusivity Information
300MG
Marketing Status: Prescription
Active Ingredient: OXCARBAZEPINE
Proprietary Name: TRILEPTAL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N021014
Product Number: 002
Approval Date: Jan 14, 2000
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status: Prescription
Patent and Exclusivity Information
TRILEPTAL (OXCARBAZEPINE)
Proprietary Name: TRILEPTAL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N021014
Product Number: 002
Approval Date: Jan 14, 2000
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status: Prescription
Patent and Exclusivity Information
600MG
Marketing Status: Prescription
Active Ingredient: OXCARBAZEPINE
Proprietary Name: TRILEPTAL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 600MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N021014
Product Number: 003
Approval Date: Jan 14, 2000
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: TRILEPTAL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 600MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N021014
Product Number: 003
Approval Date: Jan 14, 2000
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status: Prescription
Patent and Exclusivity Information